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Abstract
Background: Polymorphisms in intron 15 of potassium voltage-gated channel, KQT-like subfamily member 1
(KCNQ1) gene have been associated with type II diabetes (T2D) in Japanese genome-wide association studies
(GWAS). More recently a meta-analysis of European GWAS has detected a new independent signal associated with
T2D in intron 11 of the KCNQ1 gene. The purpose of this investigation is to examine the role of these variants with
T2D in populations of Asian Indian descent from India and the US.
Methods: We examined the association between four variants in the KCNQ1 gene with T2D and related
quantitative traits in a total of 3,310 Asian Indian participants from two different cohorts comprising 2,431
individuals of the Punjabi case-control cohort from the Sikh Diabetes Study and 879 migrant Asian Indians living in
the US.
Results: Our data confirmed the association of a new signal at the KCNQ1 locus (rs231362) with T2D showing an
allelic odds ratio (OR) of 1.24 95%CI [1.08-1.43], p = 0.002 in the Punjabi cohort. A moderate association with T2D
was also seen for rs2237895 in the Punjabi (OR 1.14; p = 0.036) and combined cohorts (meta-analysis OR 1.14; p =
0.018). Three-site haplotype analysis of rs231362, rs2237892, rs2237895 exhibited considerably stronger evidence of
association of the GCC haplotype with T2D showing OR of 1.24 95%CI [1.00-1.53], p = 0.001, permutation p = 8 ×
10
-4 in combined cohorts. The ‘C’ risk allele carriers of rs2237895 had significantly reduced measures of HOMA-B in
the US cohort (p = 0.008) as well as in combined cohort in meta-analysis (p = 0.009).
Conclusions: Our investigation has confirmed that the variation within the KCNQ1 locus confers a significant risk to
T2D among Asian Indians. Haplotype analysis further suggested that the T2D risk associated with KCNQ1 SNPs may
be derived from ‘G’ allele of rs231362 and ‘C’ allele of rs2237895 and this appears to be mediated through b cell
function.
Background
The potassium voltage-gated channel, KQT-like subfam-
ily member 1 (KCNQ1) is a member of 11 mammalian
Kv channel families and has been extensively studied for
its role in long QT syndrome. Mutations in KCNQ1
have been described to lead to cardiac long QT syn-
drome, Jervell and Lange-Nielsen syndrome, which are
associated with cardiac conduction abnormalities and
hearing loss [1]. KCNQ1 is expressed mainly in the
heart, and to lesser extent in the pancreas, placenta,
lung, liver, kidney, brain, and adipose tissue. In addition,
KCNQ1 is expressed in vitro in insulin-secreting cell
lines [2]. Insulin secretion from pancreatic b cells is
regulated by complex interplay between KATP channels
and Kv- channels and voltage-dependent Ca
++ channels
[3]. Ionic mechanisms at KATP and Kv- channels are pri-
marily important in triggering and maintaining glucose-
stimulated insulin secretion. However, the contribution
of the KCNQ1 to the molecular pathogenesis of type II
diabetes (T2D) remains to be elucidated.
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association studies (GWAS) in Japanese populations
have identified KCNQ1 as a novel T2D susceptibility
gene [4,5]. Intronic variants in the 3’ end of KCNQ1
(rs2237892, rs2237895, and rs2237897) had a strong
association with T2D. Thereafter, association of this
locus with T2D was replicated in predominantly East
Asian ethnicities including Chinese [6,7], East Asians
from Singapore [8], and in some Euro-Caucasians from
Denmark [5,9] and Sweden [10]. More recently, a meta-
analysis performed on GWAS data from European
populations revealed a new independent signal at the
KCNQ1 locus for another intronic variant (rs231362)
associated with T2D at an odds ratio (OR) of 1.08, p =
2.8 × 10
-13 [11].
Knowledge of the regulatory role of Kv channels with
glucose-stimulated insulin release and recent reports of
association of KCNQ1 with T2D prompted us to explore
the role of these variants in our unique sample from the
Punjabi community of India. The validation of GWAS
signals in multiple ethnicities is important to putatively
d e f i n et h er o l eo ft h i sg e n ei nT 2 Dp a t h o g e n e s i s .
A recent replication attempt in three populations from
Singapore could not clearly describe the role of these
KCNQ1 variants for increasing T2D susceptibility in
Asian Indians from Singapore because of the small size
of their sample [8]. To our knowledge, this is the first
study of a population from South Asia reporting the
association of two independent GWAS signals in the
KCNQ1 gene with T2D. Furthermore, this study
addresses the possible association of these markers with
T2D as one haplotype.
Methods
Human Subjects
A total of 3,310 Asian Indians participated in this study
from two different cohorts: Group 1 (n = 2,431) is the
Punjabi T2D case-control cohort which is part of the
Sikh Diabetes Study (SDS) recruited from Northern
states of India, including Punjab, Haryana, and Delhi
[12]. Group 2 (n = 879) comprises US Asian Indian par-
ticipants who are first generation immigrants from India
and are residents of the states of Oklahoma, Texas, and
California. The DNA and serum samples from a total of
1,448 T2D cases and 1,617 normoglycemic (NG) con-
trols and 245 individuals with impaired glucose toler-
ance (IGT) or impaired fasting glucose (IFG) were
studied. The NG control subjects from the Punjabi
cohort were random unrelated individuals recruited
from the same Asian Indian community as the T2D
patients and were matched for ethnicity and geographic
location. The US subjects were recruited through public
advertisement as part of a population-based study invol-
ving free health screening for cardiovascular risk factors.
Men and women aged 25-79 years participated. The
individuals with mixed ancestry or non-Asian Indian
ancestry were not enrolled. Two third of the subjects
from the US cohort were originally from the state of
Punjab, and the remaining one third were from other
western and southern states of India. The diagnoses of
T2D were confirmed by reviewing medical records for
symptoms, use of medication, and measuring fasting
glucose levels following the guidelines of the American
Diabetes Association (2004) [13], as described previously
[14]. A medical record indicating either (1) a fasting
plasma glucose level ≥7.0 mmol/L or ≥126 mg/dL after
a minimum 12h fast or (2) a 2h post-glucose level (2h
oral glucose tolerance test) ≥11.1 mmol/L or ≥200 mg/
dL on more than one occasion, combined with symp-
toms of diabetes, confirmed the diagnosis. IFG is
defined as a fasting blood glucose level ≥100 mg/dL
(5.6 mmol/L) but ≤126 mg/dL (7.0 mmol/L). IGT is
defined as a 2h OGTT > 140 mg/dL (7.8 mmol/L) but
<200 mg/dL (11.1 mmol/L). Subjects with IFG or IGT
were considered pre-diabetics and were analyzed sepa-
rately. The 2h OGTTs were performed following the
criteria of the World Health Organizations (WHO)
(75 g oral load of glucose). Body mass index (BMI) was
calculated as (weight [kg]/height [meter]
2), and waist-
to-hip ratio (WHR) was calculated as the ratio of abdo-
men or waist circumference to hip circumference.
Subjects with type I diabetes, or those having a family
member with type I diabetes, or rare forms of T2D sub-
types (maturity onset diabetes of young [MODYs]), or
secondary diabetes (from e.g. hemochromatosis, pan-
creatitis) were excluded from the study.
The selection of controls was based on a fasting glyce-
mia <100.8 mg/dL or a 2h glucose <141.0 mg/dL. Sub-
jects with IFG or IGT were excluded when data were
analyzed for association of variants with T2D. All blood
samples were obtained at the baseline visits. Insulin was
measured by radio-immuno assay (Diagnostic Products,
Cypress, USA). Homeostasis model assessment for insu-
lin resistance (HOMA-IR) was calculated as (fasting glu-
cose mg/dL × fasting insulin μIU/mL)/405 and for b cell
function (HOMA-B) (fasting insulin μIU/mL × 360)/
(fasting glucose mg/dL - 63), as described [15]. All parti-
cipants signed a written informed consent for the inves-
tigations. The study was reviewed and approved by the
University of Oklahoma Health Sciences Center’sI n s t i -
tutional Review Board, as well as the Human Subject
Protection Committees at the participating hospitals and
institutes in India.
SNP Genotyping
We genotyped four SNPs from the KCNQ1 gene. Three
SNPs (rs2237892, rs2237895 and rs2237897) were cho-
sen from intron 15 based on the strong association
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rs231362 from intron 11 was part of a new GWAS signal
reported in Caucasian meta-analysis [11]; it maps 150 kb
upstream from the Japanese GWAS signal. Genotyping for
all four SNPs was performed using TaqMan pre-designed
or TaqMan made-to-order SNP genotyping assays from
Applied Biosystems Inc. (ABI, Foster City, USA). Genotyp-
ing reactions were performed on an ABI 7900 genetic ana-
lyzer using 2 uL of genomic DNA (10 ng/uL), following
manufacturers’ instructions. For quality control, 8-10%
replicative controls and 4-8 negative controls were used in
each 384 well plate to match the concordance, and the dis-
crepancy rate in duplicate genotyping was <0.2%. Geno-
typing call rate was 97% or more in all the SNPs studied.
Statistical Analysis
Data quality for SNP genotyping was checked by estab-
lishing reproducibility of control DNA samples. Depar-
ture from Hardy-Weinberg equilibrium (HWE) in
controls was tested using the Pearson chi-square test.
The genotype and allele frequencies in T2D cases were
compared to those in control subjects using the chi-
square test. Statistical evaluation of genetic effects on
T2D risk used multivariate logistic regression analysis
with adjustments for age, gender, and other covariates.
Continuous traits with skewed sampling distributions
( e . g .g l u c o s e ,i n s u l i n ,H O M A - I R ,a n dH O M A - B )w e r e
log-transformed before statistical analysis. However, for
illustrative purposes, values were re-transformed into the
original measurement scale. General linear models were
used to test the impact of genetic variants on trans-
formed continuous traits (FBG, 2h glucose, HOMA-IR,
and HOMA-B) only in NG controls and pre-diabetics +
NG controls. Patients were excluded due to confounding
effect of glucose lowering medications. Place of birth was
used as covariate while analyzing combined sample of the
Punjabi and US cohorts. Other significant covariates for
each dependent trait were identified by Spearman’sc o r -
relation and step-wise multiple linear regression with an
overall 5% level of significance using SPSS for Windows
statistical package (version 18.0) (SPSS Inc., Chicago,
USA). Mean values between cases and controls were
compared by using an unpaired t-test.
Haplotype analysis of three KCNQ1 SNPs was per-
formed using HAPLOVIEW (version 4.0) (http://www.
broadinstitute.org/haploview/haploview) which uses an
accelerated expectation maximization algorithm to cal-
culate haplotype frequencies. Effect of three-site haplo-
types on T2D and quantitative variables were
determined using PLINK (version 1.0.6) (http://pngu.
mgh.harvard.edu/~purcell/plink/). Meta-analysis was
performed by using PLINK for fixed-effects and ran-
dom-effects models and p value for heterogeneity was
derived from Cochrane’s Q statistics. To adjust for mul-
tiple testing, we used Bonferroni’s correction (0.05/num-
ber of tests performed).
Statistical power was assessed using the Genetic Power
Calculator [16]. The general estimates of power in the
Punjabi and combined sample using additive genetic
model at a = 0.05, K = 0.18 for detecting the effect
sizes between 1.11 (rs231362) and 1.49 (rs2237895) for
T2D, were 56% and 89% in the Punjabi and 66% and
97% in combined cohorts, respectively, when the fre-
quency of risk alleles of rs231362 and rs2237895 were
0.73 and 0.42, respectively, in our sample. Our sample
lacked power to detect the association of remaining
SNPs (rs2237892 and rs2237897) with T2D because
these two SNPs were least frequent in our cohorts with
the minor allele frequency (MAF) ranging from 1-2%.
However, for quantitative traits, the power was well in
excess (90%) to detect the inter-genotype difference (e.g.
for FBG levels), assuming an additive genetic model,
(a = 0.05, and Bonferroni’s p = 0.008) at allele frequen-
cies ranging from 0.41-0.98 using 1,048, 569, and 1,617
controls from the Punjabi, US, and combined cohorts,
respectively. This power is associated to detect a differ-
ence in a quantitative trait of FBG of as little as 1 mg/dL
and accounts for an effect size of 0.1 which corresponds
to detecting significant bs outside of the range of ± 0.05.
Results
Table 1 summarizes and compares the general charac-
teristics of the two study cohorts used in this investiga-
tion. Among these subjects, the US cohort was younger
and had earlier onset of T2D (42 years) compared to
the Punjabi cohort (48 years). Diabetics in the Punjabi
cohort had poor glycemic control showing significantly
higher FBG levels (by 17 mg/dL) (p = 0.002) compared
to the US cohort. HOMA-B (used as a surrogate marker
for beta [b] cell function) were also significantly lower
(by 33 units) (p = 4.64 × 10
-8) and WHR significantly
higher (by 5 units) (p <0.001) in the Punjabi cohort.
The physical location and inter-marker distance of all
investigated SNPs is shown in Figure 1. Linkage disequi-
librium (LD) analysis revealed that all investigated SNPs
were in very modest LD (D’ ranging from 0.06-0.65) and
showed poor correlation (r
2 = 0.00-0.41) with each
other. We did not continue genotyping rs2237897 after
initial screening of 1,507 samples (815 T2D/692 con-
trols) as this SNP was least frequent in our population;
MAF in controls was 1% (additional file 1 Table S1).
Compared to all other SNPs, this least frequent SNP
was relatively in stronger LD with rs2237892 (D’ =0 . 6 5 ,
r
2 = 0.41). However, none of the three Japanese GWAS
SNPs (rs2237892, rs2237895 and rs2237897) was corre-
lated with rs231362 (r
2<0.005) (Figure 1).
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Allelic distribution of all investigated SNPs was in HWE
among controls. Two of the three SNPs were associated
with T2D in our sample. The strongest association with
T2D was seen in rs231362, which remained significant
even after adjusting for the effects of age, gender, and
BMI. A common ‘G’ allele conferred a significant risk
under additive genetic model in the Punjabi (1.24; 95%CI
[1.08-1.43], p = 0.002) and combined cohorts (1.21; 95%
CI [1.06-1.37], p = 0.004). Meta-analysis revealed a signif-
icant association of this variant in fixed-effects (p =
0.009) but not in random-effects model (p = 0.390),
despite the fact that Cochrane’s Q statistics did not reveal
any significant evidence of heterogeneity between these
two data sets (p = 0.114). A moderate association with
T2D was also seen in rs2237895 in the Punjabi (1.14;
95%CI [1.01-1.28], p = 0.036) and the combined cohorts
(1.15; 95%CI [1.03-1.29], p = 0.011) after adjusting for
covariates of age, gender, BMI and place of birth, and
this association remained significant in the meta-analysis
(1.14, p = 0.018). On the other hand, a non-significant
association of rs2237892 with T2D became slightly signif-
icant in the meta-analysis both in fixed-effects (p = 0.03)
and random-effects models (p = 0.03) (Table 2).
Association of KCNQ1 variants with quantitative
traits related to obesity and T2D
We investigated the association of KCNQ1 variants with
quantitative traits associated with obesity and glucose
homeostasis including only non-diabetic individuals.
Multiple linear regression analysis revealed a moderately
significant association of ‘A’ allele of rs231362 with WHR
in the Punjabi cohort (b = -0.02 p = 0.01). A significant
decrease in HOMA-B levels, associated with the ‘C’ risk
allele of rs2237895, was observed in the US cohort (p =
0.008) as well as in the meta-analysis both for fixed-
effects (p = 0.009) and random-effects (p = 0.009) models
(Table 3). This variant also showed a significant associa-
tion with HOMA-B even in the combined sample includ-
ing NG and IFG+IGT (b = -0.19; 95%CI [-0.33- -0.06],
p = 0.005) (additional file 1 Table S2).
Haplotype analysis
To determine whether these SNPs demonstrate any addi-
tional evidence of association with T2D when examined
together, we performed a haplotype analysis. As shown in
Table 4, the three-site haplotype analysis using rs231362,
rs2237892 and rs2237895 revealed a significant difference
in the distribution of haplotype among cases and controls
in both the Punjabi and combined cohorts showing signifi-
cant global c
2 (c3
2 = 12.9, p = 0.005 and c3
2 =1 4 . 1 ,p=
0.003), respectively. The least frequent variant (rs2237897)
was not included in haplotype analysis. The second most
frequent haplotype (GCC) was significantly more prevalent
among T2D cases (0.34) compared to NG controls (0.30)
in both the Punjabi (p = 0.002) as well as combined
cohorts (p = 4.07 × 10
-4). Association of the GCC haplo-
type with T2D remained significant after adjusting for age,
Table 1 Clinical characteristics of study populations (Mean ± SD)
Punjabi Cohort US Cohort Combined
n = 2,431 n = 879 n = 3,310
Age (yrs.) 53.5 ± 12.9 48.0 ± 13.5 52.1 ± 13.3
% Males 52.5 51.7 52.3
Age at Diagnosis (yrs.) 47.6 ± 11.1 42.4 ± 18.9 47.4 ± 11.6
Duration of Diabetes (yrs.) 7.6 ± 6.8 6.8 ± 7.1 7.6 ± 6.8
BMI (kg/m
2) 26.9 ± 5.1 26.9 ± 4.5 26.9 ± 5.0
Waist (cm) 93.2 ± 12.4 92.5 ± 13.4 93.0 ± 12.7
WHR 0.95 ± 0.07 0.90 ± 0.13* 0.94 ± 0.10
FBG (mg/dL)
Non-Diabetic 95.0 ± 13.4 98.5 ± 13.0 96.6 ± 13.3
Diabetic 162.7 ± 62.4 145.9 ± 42.7** 160.8 ± 60.4
2h glucose (mg/dL)
Non-Diabetic 107.1 ± 23.2 115.4 ± 24.8 111.4 ± 24.4
Diabetic 201.2 ± 69.2 228.2 ± 72.8
¥ 209.1 ± 71.3
Fasting Insulin (IU/mL) 6.6 (6.3 - 6.9) 7.4 (7.1 - 7.8) 6.8 (6.6 - 7.1)
HOMA-IR 2.1 (2.0 - 2.2) 1.9 (1.8 - 2.0) 2.0 (1.9 - 2.1)
HOMA-B 37.9 (35.5 - 40.4) 71.4 (67.5 - 75.5)
 45.7 (43.5 - 48.1)
NG
† (%) 43.1 64.7 48.9
T2D
‡ (%) 53.8 16.0 43.7
IGT/IFG (%) 3.1 19.2 7.4
†Normoglycemic;
‡Type II Diabetes; Impaired glucose tolerance, Impaired fasting glucose. *p < 0.001; **p = 0.002;
¥p = 0.02 (showing significant difference in the
Punjabi and US cohorts);
p = 4.64 × 10
-8; Skewed variables (insulin, HOMA-IR and HOMA-B) are presented in mean (95% confidence intervals).
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1.65], p = 0.004 [adjusted], p = 0.006 [permutation]), and
adjusting for age, gender, BMI, and place of birth in com-
bined cohorts (1.24 95%CI [1.00-1.53], p = 0.001
[adjusted], p = 8 × 10
-4 [permutation]) (Table 4).
Discussion
Three variants (rs2237892, rs2237895, and rs2237897)
from intron 15 of the KCNQ1 gene were the SNPs most
frequently associated with T2D and fasting insulin levels
in previous studies on East Asian populations [4,5,8].





5'  3' 
;Ϳ
;Ϳ
Figure 1 describes structure of human KCNQ1 gene on chromosome 11. Top portion of the Figure 1 shows the position of four
investigated SNPs from intron 11 and 15. Figure 1(A) shows pair-wise linkage disequilibrium (LD) (D’) and Figure 1(B) shows pair-wise correlation
(r
2) between SNPs.
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or rs2237897 with T2D or fasting serum insulin levels in
our Asian Indian sample and these findings are in agree-
ment with the absence of association with these variants
seen in other Caucasian studies [17-19]. Perhaps a signifi-
cant ethnic difference in the allelic distribution could be
the reason of non-replication as the MAF of these SNPs
was significantly lower in our sample compared to East
Asian populations: 2-3% vs. 28-41%, respectively, for
rs2237892 and 1% vs. 28-39%, respectively, for rs2237897
[4-6,8]. Given the low allele frequency of rs2237892 and
rs2237897 in Asian Indians, the statistical power of our
study to identify any association with T2D or related
metabolic traits is low, which may explain the lack of
association with these SNPs in our sample. Moreover,
our data revealed a significant variation in LD patterns in
these SNPs compared to East Asians; for instance, there
was a strong LD between rs2237892, rs2237895 and
rs2237897 SNPs in East Asians (D’ = 0.84-0.98, r
2 = 0.20-
0.66) [7] compared to our Asian Indian cohort (D’ =
0.51-0.65, r
2 = 0.0-0.41). These differences can also
increase or decrease the disease risk; best example for
this is the negative association of TCF7L2 SNPs with
T2D in Chinese [20]. Nevertheless, despite those differ-
ences, our data replicated a strong association of a new
GWAS signal at the KCNQ1 locus (rs231362) with T2D
(1.24, p = 0.002) in our Punjabi cohort, identified recently
in Caucasian meta-analysis [11]. This association appears
to be independent of the other SNPs (rs2237892,
rs2237895 and rs2237897) as these 3’SNPs were poorly
correlated with rs231362 (D’ = 0.06-0.14, r
2 = 0.00) in
our sample. A similar poor correlation of these SNPs
Table 2 Genotype distribution and association of KCNQ1 SNPs with T2D
Punjabi Cohort (n =
2,355)
US Cohort (n = 710) Combined (n = 3,065)**
SNP Genotype NG
† (%) T2D
¥ (%) Odds Ratios
(OR)* (95%CI)
P-value
NG (%) T2D (%) Odds
Ratios
††
(95%CI)
P-value
NG (%) T2D (%) Odds
Ratios
††
(95%CI)
P-value
rs231362 GG 559 (54) 779 (60) unadjusted
1.25
(1.09 - 1.43)
328 (58) 81 (57) unadjusted
0.97
(0.72 - 1.29)
887 (56) 860 (60) unadjusted
1.18
(1.05 - 1.33)
GA 395 (38) 437 (34) 0.001 191 (34) 49 (35) 0.823 586 (37) 486 (34) 0.005
AA 78 (8) 71 (6) adjusted
1.24
(1.08 - 1.43)
42 (8) 11 (8) adjusted
1.04
(0.75 - 1.45)
120 (7) 82 (6) adjusted
1.21
(1.06 - 1.37)
ΨG/A 0.73/0.27 0.78/0.22 0.002 0.75/0.25 0.75/0.25 0.798 0.74/0.26 0.77/0.23 0.004
rs2237892 CC 982
(96.3)
1259 (97.6) unadjusted
1.49
(0.94 - 2.37)
523 (93.9) 133 (95.7) unadjusted
1.48
(0.63 - 3.47)
1505 (95.5) 1392 (97.4) unadjusted
1.74
(1.18 - 2.56)
CT 36 (3.5) 30 (2.3) 0.094 32 (5.7) 6 (4.3) 0.368 68 (4.3) 36 (2.5) 0.005
TT 1 (0.1) 1 (0.1) adjusted
1.44
(0.89 - 2.31)
2 (0.4) 0 (0) adjusted
2.35
(0.88 - 6.30)
3 (0.2) 1 (0.1) adjusted
1.53
(1.01 - 2.32)
C/T 0.98/0.02 0.99/0.01 0.136 0.97/0.03 0.98/0.02 0.088 0.98/0.02 0.99/0.01 0.046
rs2237895 AA 359 (35) 410 (32) unadjusted
1.11
(0.99 - 1.25)
206 (38) 40 (29) unadjusted
1.32
(1.02 - 1.70)
565 (36) 450 (32) unadjusted
1.15
(1.04 - 1.27)
AC 473 (46) 610 (47) 0.068 249 (45) 67 (48) 0.037 722 (46) 677 (48) 0.006
CC 188 (18) 265 (21) adjusted
1.14 (1.01-1.28)
96 (17) 32 (23) adjusted
1.24
(0.93 - 1.66)
284 (18) 297 (20) adjusted
1.15
(1.03 - 1.29)
A/C 0.58/0.42 0.56/0.44 0.036 0.60/0.40 0.53/0.47 0.146 0.59/0.41 0.55/0.45 0.011
Meta-analysis
SNP Risk Allele P-value
(Fixed
Effect)
P-value
(Random
Effect)
OR (Fixed
Effect)
OR
(Random
Effect)
P-value
(Heterogeneity)
rs231362 G 0.009 0.390 1.15 1.11 0.114
rs2237892 C 0.030 0.030 1.37 1.37 0.522
rs2237895 C 0.018 0.021 1.14 1.14 0.313
* Allelic ORs for Punjabi cohort were adjusted for age, sex, and BMI;
†Normoglycemic;
¥ type II diabetes;
Ψ letters in bold indicate risk allele; **Subjects with
impaired glucose tolerance (IGT) or impaired fasting glucose (IFG) were excluded from analysis; Bonferroni p-value for three SNPs using 3 genetic models =
0.0055;
†† ORs for US and combined analysis were adjusted for age, gender, BMI, and place of birth.
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analysis (r
2 = 0.05) [11]. It is possible that the observed
association of rs231362 with T2D could be mediated by
obesity, as the same T2D protective ‘A’ allele is linked
with low WHR among NG controls in the Punjabi cohort
(p = 0.01). However, after controlling for the effect of
WHR, the significance of this association with T2D did
not disappear (p = 0.003), suggesting that the association
of this SNP with T2D could be independent of the path-
way related to obesity. Additionally, our data also showed
a moderate association of the rs2237895 variant with
T2D in the Punjabi (OR 1.14, p = 0.036) and in meta-
analysis (OR 1.14, p = 0.02). However, after applying
Bonferroni’s correction for multiple testing, these asso-
ciations did not remain statistically significant. On the
other hand, the same variant (rs2237895) revealed a
strong association with HOMA-B in both the US
(adjusted p = 0.008; Bonferroni p = 0.008) as well as in
meta-analysis (p = 0.009), which may increase the risk of
insulin resistance and T2D susceptibility in this popula-
tion. A non-significant trend associated with HOMA-B
in the same direction was also observed our Punjabi
cohort. The measures on fasting insulin were only avail-
able on 63% of NG controls from the Punjabi cohort
which also could have contributed to less significant
association with HOMA-B in this cohort. In addition, the
Punjabi cohort had poor b cell function as indicated by
their significantly lower HOMA-B levels compared to the
US cohort (p = 4.64 × 10
-8) (Table 1). Perhaps, relatively
younger mean age (5.5 years) of the US cohort, sample
Table 3 Multiple regression analysis showing association between SNPs in KCNQ1 and obesity and diabetes-related
metabolic traits among non-diabetic controls
Punjabi Cohort (n = 1,048) rs231362 rs2237892 rs2237895
Trait Mean b (95%CI) p
adjusted
Ψ
b (95%CI) p
adjusted
b (95%CI) p
adjusted
BMI (kg/
m
2)
26.26 (25.94 - 26.58) 0.01 (-0.59 - 0.71) 0.860 -0.05 (-3.03 - 0.46) 0.150 0.04 (-0.23 - 1.13) 0.192
WHR 0.94 (0.93 - 0.94) -0.02 (-0.04 - -0.01) 0.010 0.00 (-0.03 - 0.03) 0.992 -0.01 (-0.02 - 0.00) 0.149
FBG
(mg/dL)
95.18 (94.30 - 96.05) -0.04 (-0.02 - 0.01) 0.220 -0.06 (-0.08 - 0.01) 0.088 -0.01 (-0.03 - 0.01) 0.310
INSULIN
(IU/mL)
7.35 (6.82 - 7.92) 0.06 (-0.03 - 0.28) 0.107 0.03 (-0.25 - 0.52) 0.496 -0.06 (-0.21 - 0.18) 0.870
HOMA-IR 1.66 (1.54 - 1.80) -0.04 (-0.46 - 0.15) 0.309 0.02 (-0.30 - 0.49) 0.634 -0.11 (-0.32 - 0.93) 0.282
HOMA-B 85.09 (77.74 - 93.14) 0.05 (-0.06 - 0.27) 0.223 0.07 (-0.08 - 0.81) 0.106 -0.07 (-0.43 - 0.03) 0.091
US Cohort (n = 569) rs231362 rs2237892 rs2237895
Trait Mean b (95%CI) p
adjusted
Ψ
b (95%CI) p
adjusted
b (95%CI) p
adjusted
BMI (kg/
m
2)
26.19 (25.83 - 26.55) 0.07 (-.030 - 2.43) 0.124 0.09 (0.11 - 2.90) 0.034 0.07 (-0.08 - 1.34) 0.082
WHR 0.88 (0.87 - 0.89) -0.02 (-0.04 - 0.00) 0.197 -0.04 (-0.26 - 0.10) 0.395 -0.04 (-0.05 - 0.01) 0.289
FBG
(mg/dL)
95.95 (95.05 - 96.85) -0.01 (-0.03 - 0.00) 0.086 0.04 (-0.02 - 0.06) 0.373 0.03 (-0.02 - 0.03) 0.536
INSULIN
(IU/mL)
6.72 (6.37 - 7.09) 0.04 (-0.05 - 0.12) 0.393 0.01 (-0.99 - 1.19) 0.862 -0.09 (-0.15 - -0.05) 0.037
HOMA-IR 1.57 (1.49 - 1.66) 0.02 (-0.17 - 0.25) 0.704 0.02 (-0.20 - 0.34) 0.622 -0.11 (-0.30 - -0.03) 0.015
HOMA-B 79.71 (74.87 - 84.86) 0.09 (-0.01 - 0.25) 0.062 -0.03 (-0.43 - 0.20) 0.490 -0.13 (-0.37 - -0.06) 0.008
Meta-analysis (n = 1,617) rs231362 rs2237892 rs2237895
Trait Mean P(F)
1 P(R)
2 P(H)
3 P(F) P(R) P(H) P(F) P(R) P(H)
BMI (kg/
m
2)
26.23 (25.99 - 26.48) 0.856 0.849 0.051 0.640 0.990 0.010 0.463 0.463 0.670
WHR 0.91 (0.91 - 0.92) 0.840 0.840 0.445 0.396 0.396 0.932 0.118 0.118 0.399
FBG
(mg/dL)
95.48 (94.84 - 96.12) 0.020 0.020 0.551 0.555 0.553 0.284 0.596 0.725 0.133
INSULIN
(IU/mL)
7.09 (6.75 - 7.46) 0.467 0.653 0.032 0.012 0.488 0.003 0.248 0.248 0.539
HOMA-IR 1.62 (1.54 - 1.71) 0.689 0.689 0.738 0.078 0.630 0.001 0.616 0.616 0.680
HOMA-B 82.71 (78.06 - 87.63) 0.062 0.062 0.912 0.475 0.766 0.293 0.009 0.009 0.532
ΨP values were adjusted for age, gender and BMI in the Punjabi cohort; age, gender, BMI and place of birth in US cohorts; Bonferroni p = 0.008;
1p-value for
fixed effect;
2p-value for random effect;
3 p-value for heterogeneity; measures on serum insulin, HOMA-IR, and HOMA-B were available in 657 of 1,048 control
individuals in the Punjabi cohort.
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Page 7 of 10heterogeneity, and/or migration might be contributing
for this difference that has resulted in genotype difference
in affecting HOMA-B levels.
The role of these KCNQ1 variants for increasing T2D
susceptibility is further substantiated when we tested
these three variants together (rs231362, rs2237892,
rs2237895) using haplotype analysis. The at-risk GCC
haplotype revealed a strong association with T2D and
conversely, the ACA haplotype revealed a significant
protection in both Punjabi and combined cohorts and a
non-significant trend was also noticed in US cohort.
Notably, in haplotype analysis, it appears that the ‘G’
allele of rs231362 contributes to T2D risk only in the
presence of ‘C’ allele of rs2237895 on GCC haplotype
and not when it is on GCA haplotype. These findings
suggest that the observed association of GCC haplotype
of with T2D may be derived from rs231362 and
rs2237895. Interestingly, the increased T2D risk asso-
ciated with the GCC haplotype and decreased T2D risk
associated with ACA haplotype remained unchanged
after including HOMA-IR along with other covariates
(age and gender) in the model showing ORs of (1.21;
95%CI [1.08-1.37], p = 0.001) for GCC and (0.77; 95%CI
[0.64-0.92], p = 0.004) for ACA. These results further
suggest that the KCNQ1 risk with T2D may be mediated
through b cell function rather insulin resistance. To
further understand the mechanism of association of this
GCC haplotype with T2D, we investigated whether
these haplotypes have any role in affecting T2D-related
quantitative phenotypes. Our data could not verify asso-
ciation of any of these haplotypes with quantitative phe-
notypes related to obesity (BMI, waist and WHR) and
glucose homeostasis (FBG, 2h glucose, HOMA-IR and
HOMA-B) (data not presented).
Although, these results have independently replicated a
strong association of rs231362 with T2D and also a strong
association of the GCC halpotype with T2D in this Asian
Indian sample, these data provided little guidance in deter-
mining the putative role of these variants (individually or
in haplotype combination) in the biology of T2D. Even the
variant showing strongest association with T2D in Punjabi
cohort in single SNP analysis (rs231362) was weakly corre-
lated with FBG (p = 0.02) and HOMA-B (p = 0.062) in
meta-analysis (Table 3). These findings are in agreement
with the previous Caucasian studies, and suggest the possi-
bility of different mechanisms controlling normal glucose
homeostasis and the development of T2D [11]. On the
other hand, our results showed a strong association of
rs2237895 with HOMA-B indicating that the NG indivi-
duals who carried the at-risk ‘C’ allele also had reduced
measures of fasting serum insulin (p = 0.037) and signifi-
cantly reduced HOMA-B levels in the US cohort (p =
0.008) and also was revealed a strong association with
HOMA-B in meta-analysis (p = 0.009). A similar
Table 4 Estimated haplotype probabilities and c2- test showing haplotype association between KCNQ1 SNPs
(rs231362, rs2237892, rs2237895) and T2D
Punjabi Cohort
Haplotype NG T2D c
2 Adjusted OR (95%CI) Unadjusted p Adjusted p Permutation p (5000)
ACC 0.12 0.11 1.94 0.86 (0.70 -1.05) 0.145 0.184 0.489
GCC 0.30 0.34 7.65 1.22 (1.07 -1.39) 0.002 0.004 0.006
ACA 0.14 0.12 7.39 0.74 (0.61-0.90) 0.003 0.007 0.019
GCA 0.44 0.44 0.02 1.02 (0.91-1.15) 0.743 0.836 0.997
global c
2 = 12.9, df = 3, p = 0.005
US Cohort
Haplotype NG T2D c
2 Adjusted OR (95%CI) Unadjusted p Adjusted p Permutation p (5000)
ACC 0.10 0.13 1.61 1.67 (1.03 - 2.72) 0.142 0.135 0.507
GCC 0.30 0.35 2.58 1.22 (0.90 - 1.65 ) 0.137 0.101 0.496
ACA 0.14 0.11 1.53 0.72 (0.44 - 1.17) 0.350 0.233 0.878
GCA 0.46 0.41 2.06 0.88 (0.66 - 1.19) 0.176 0.197 0.575
global c
2 = 7.05, df = 3, p = 0.070
Combined (Punjabi + US Cohorts)
Haplotype NG T2D c
2 Adjusted OR (95%CI) Unadjusted p Adjusted p Permutation p (5000)
ACC 0.12 0.11 0.31 0.96 (0.80 -1.15) 0.644 0.611 0.985
GCC 0.30 0.34 10.1 1.22 (1.09 -1.36) 4.07 × 10
-4 0.001 8.00 × 10
-4
ACA 0.14 0.12 8.37 0.77 (0.64 -0.91) 0.002 0.002 0.011
GCA 0.44 0.44 0.45 0.98 (0.88 -1.09) 0.734 0.826 0.991
global c
2 = 14.1, df = 3, p = 0.003
Analysis were adjusted for age, gender and BMI in the Punjabi cohort; age, gender, BMI, and place of birth in US and combined (Punjabi + US) cohorts.
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impaired b cell function was reported in other study per-
formed in Danish [9] and Scandinavian populations [10].
Incidentally, the MAF of this variant in Danes (42.5%) was
also similar to our Asian Indian sample (41%). Also, con-
sistent with our study, no other KCNQ1 variant was asso-
ciated with insulin secretion or b cell function in Danes.
The small size of our US cohort is a limitation of our
study as the observed association of rs231362 with T2D in
our primary (Punjabi) cohort could not be confirmed in
the US cohort due to small size and/or cohort heterogene-
ity, although the cohort heterogeneity could not confirmed
through Cochrane statistics in meta-analysis (p[heteroge-
neity] = 0.114), perhaps, because only two datasets were
meta-analyzed (Table 2). Also, the MAF in all these SNPs
did not vary significantly among NG individuals of the
Punjabi and US cohort (0.27 vs. 0.25 for rs231362, 0.02 vs.
0.03 in rs2237892, and 0.42 vs. 0.40 in rs2237895), respec-
tively. Therefore, future confirmation of these results,
including association of haplotypes on larger cohorts from
South Asia will help verify the association of KCNQ1 with
T2D in the populations of Indian sub-continent.
Conclusions
Our study has replicated a previously reported association
of rs231362 with T2D in a non-Caucasian and non- East
Asian sample from Punjab, India. Our haplotype data have
further revealed a strong association of the GCC haplotype
with T2D in this sample. Our results have also indepen-
dently confirmed the association of rs2237895 with
H O M A - B ,w h i c hm a yb el i n k e dt ob cell dysfunction.
However, as the overall risk explained by these SNPs for
susceptibility to T2D or b cell dysfunction is <1.3, further
functional studies are warranted to clearly delineate the
role of the KCNQ1 locus in normal glucose homeostasis
and T2D pathogenesis. Perhaps these SNPs are good
proxies for the yet undetected causal SNP which could be
part of this gene or nearby genes. Extensive dense geno-
typing and resequencing in this region should identify cau-
sative variants in the KCNQ1 locus explaining its
functional association with insulin secretion and T2D.
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